TITLE

Discontinuing Inhaled Steroids in COPD Patients

AUTHOR(S)
Carter, Chuck
PUB. DATE
April 2003
SOURCE
American Family Physician;4/15/2003, Vol. 67 Issue 8, p1803
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the study 'Effect of Discontinuation of Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease,' by P. Van der Valk et al., from the November 15, 2002 issue of the 'American Journal of Respiratory and Critical Care Medicine.'
ACCESSION #
9610398

 

Related Articles

  • Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease. Bonay, M.; Bancal, C.; Crestani, B.; Bonay, Marcel; Bancal, Catherine; Crestani, Bruno // Drug Safety;2002, Vol. 25 Issue 1, p57 

    Inhaled corticosteroids have a proven benefit in the management of asthma, but until recently, their efficacy in non-asthmatic, smoking-related chronic obstructive pulmonary disease (COPD) was not evidence-based. Airway inflammation in COPD differs from inflammation in asthma. Some studies have...

  • Inhaled corticosteroids and COPD exacerbations. Kuritzky, Louis // Internal Medicine Alert;3/29/2010, Vol. 32 Issue 6, p48 

    The article reports on the effectiveness of inhaled corticosteroids (ICS) in treating acute exacerbations of chronic obstructive pulmonary disease (AC-COPD).

  • High-dose steroids cut COPD deaths. Polak, Monika // GP: General Practitioner;2/3/2003, p17 

    Reports on a study published in the 'European Respiratory Journal' stating that treating patients with medium and high dose of inhaled corticosteroids after discharge from hospital from chronic obstructive pulmonary disease (COPD) have a lower risk of deaths. Doses of steroids for patients with...

  • Combination therapy in COPD benefits patients.  // Practice Nurse;3/14/2003, Vol. 25 Issue 5, p19 

    Presents a study about the significance of combining an inhaled long-acting beta[sub2]-agonist with an inhaled corticosteroid to patients with chronic obstructive pulmonary disease. Reduction in exacerbations in the combined group compared with reductions in the monotherapy groups; Difference...

  • Q/What are the benefits and risks of inhaled corticosteroids for COPD? Hamilton, Tanya; Miller, John B.; Vincent, E. Chris; St. Anna, Leilani; Guthmann, Richard // Journal of Family Practice;May2014, Vol. 63 Issue 5, p276 

    The article provides an answer to a question regarding the benefits and risks of inhaled corticosteroids for chronic obstructive pulmonary disease (COPD).

  • Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. Burge, P S // BMJ: British Medical Journal (International Edition);05/13/2000, Vol. 320 Issue 7245, p1297 

    Presents information on a study which determined the effect of long term inhaled corticosteroids on lung function, exacerbations and health status in patients with obstructive pulmonary disease. Methodology; Results and discussion.

  • Corticosteroids for exacerbations of COPD. Elliott, William T. // Neurology Alert;Aug2010 Pharmacology, p2 

    The article presents a study published in the "Journal of the American Medical Association" which showed that lower doses of corticosteroids taken orally are as effective as higher doses of IV steroids in the treatment of acute exacerbation of chronic obstructive pulmonary disease (ae-COPD).

  • Inhaled corticosteroids and COPD exacerbations. Kuritzky, Louis // Primary Care Reports;Apr2010 Clinical Briefs, p8 

    The article discusses research being done on inhaled corticosteroids and chronic obstructive pulmonary disease (COPD), referencing the study "Inhaled Corticosteroids vs. Placebo for Preventing COPD Exacerbations: A Systematic Review and Metaregression of Randomized Controlled Trials," by R....

  • Inhaled corticosteroids and COPD exacerbations. Kuritzky, Louis // Clinical Oncology Alert;Apr2010 Supplement 2, p8 

    The article discusses research on the effectiveness of inhaled corticosteroids (ICS) in preventing chronic obstructive pulmonary disease (COPD) exacerbation, by R. Agarwal and colleagues, published in the 2010 issue of "Chest."

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics